Fidelis Capital Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.99M Buy
9,602
+1,283
+15% +$476K 0.23% 87
2026
Q1
$2.25M Sell
8,319
-1,512
-15% -$450K 0.16% 113
2025
Q4
$3.25M Buy
9,831
+185
+2% +$62.7K 0.24% 85
2025
Q3
$3.33M Buy
9,646
+1,006
+12% +$304K 0.26% 79
2025
Q2
$2.12M Sell
8,640
-829
-9% -$317K 0.19% 91
2025
Q1
$3.96M Sell
9,469
-487
-5% -$249K 0.42% 49
2024
Q4
$5.46M Buy
9,956
+1,600
+19% +$909K 0.55% 36
2024
Q3
$4.72M Buy
8,356
+201
+2% +$114K 0.56% 34
2024
Q2
$4.62M Buy
8,155
+306
+4% +$150K 0.66% 28
2024
Q1
$3.88M Buy
7,849
+680
+9% +$346K 0.59% 33
2023
Q4
$3.77M Buy
7,169
+1,669
+30% +$890K 0.83% 23
2023
Q3
$2.77M Buy
5,500
+286
+5% +$141K 0.95% 19
2023
Q2
$2.51M Buy
5,214
+195
+4% +$95.4K 0.91% 18
2023
Q1
$2.48M Buy
5,019
+2,075
+70% +$1M 1.05% 15
2022
Q4
$1.44M Buy
+2,944
New +$1.56M 1.7% 11

Other funds holding UNH

Fidelis Capital Partners's UNH Position: Q2 2026 in Review

Fidelis Capital Partners increased its UnitedHealth (UNH) stake by 15% in Q2 2026, buying an estimated $476K and bringing the position to 9,602 shares worth $3.99M. The position accounts for 0.23% of the portfolio, ranked #87.

Fidelis Capital Partners first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.46M in Q4 2024. 3,379 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Fidelis Capital Partners held 9,602 shares of UnitedHealth worth $3.99M as of Q2 2026.
  • Fidelis Capital Partners bought 1,283 UnitedHealth shares in Q2 2026, an estimated $476K.
  • UnitedHealth made up 0.23% of Fidelis Capital Partners's portfolio in Q2 2026, its #87 holding.
  • Fidelis Capital Partners first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • Fidelis Capital Partners's UnitedHealth position peaked at $5.46M in Q4 2024.
  • 3,379 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.